*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter - as a primary diagnosis code | T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 5.59 | |
Readmission Rate (%) | 19.7 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 71,748 | |
Total Hospitalizations with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 46 | |
DRG Share of Total Hospitalizations | 0.22 | |
% of Total ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter in DRG | 54.12 | |
Avg LOS at DRG | 2.93 | |
Avg LOS with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 2.85 | |
Readmission Rate at DRG | 33.86 | |
Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | |
Unplanned Readmission Rate at DRG | 10.34 | |
Unplanned Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | |
Total Medicare payments at DRG | $313,351,773 | |
Total Medicare payments with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $194,038 | |
Total Medicare payment per Day at DRG | $1,489 | |
Total Medicare payment per Day with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $1,481 | |
Total Medicare payment per Hospitalization at DRG | $4,367 | |
Total Medicare payment per Hospitalization with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $4,218 | |
Total Medicare Charges at DRG | $1,750,048,705 | |
Total Medicare Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $805,001 | |
Avg Charges at DRG | $24,392 | |
Avg Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $17,500 | |
Mortality Rate at DRG | 0.22 | |
Mortality Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | |
SNF Discharge Rate at DRG | 7.61 | |
SNF Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | |
Home Discharge Rate at DRG | 51.88 | |
Home Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 69.57 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,808,415 | ||||
Total Hospitalizations with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 1,223 | ||||
DRG Share of Total Hospitalizations | 5.5 | ||||
% of Total ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter in DRG | 8.1 | ||||
Avg LOS at DRG | 6.34 | ||||
Avg LOS with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 6.76 | ||||
Readmission Rate at DRG | 24.2 | ||||
Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 19.59 | ||||
Unplanned Readmission Rate at DRG | 16.78 | ||||
Unplanned Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 13.54 | ||||
Total Medicare payments at DRG | $21,288,214,047 | ||||
Total Medicare payments with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $13,890,911 | ||||
Total Medicare payment per Day at DRG | $1,857 | ||||
Total Medicare payment per Day with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $1,681 | ||||
Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
Total Medicare payment per Hospitalization with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $11,358 | ||||
Total Medicare Charges at DRG | $107,155,481,388 | ||||
Total Medicare Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $64,203,553 | ||||
Avg Charges at DRG | $59,254 | ||||
Avg Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $52,497 | ||||
Mortality Rate at DRG | 12.11 | ||||
Mortality Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 4.09 | ||||
SNF Discharge Rate at DRG | 27.18 | ||||
SNF Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 25.76 | ||||
Home Discharge Rate at DRG | 25.81 | ||||
Home Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 36.47 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 499,133 | ||||
Total Hospitalizations with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 475 | ||||
DRG Share of Total Hospitalizations | 1.52 | ||||
% of Total ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter in DRG | 3.15 | ||||
Avg LOS at DRG | 4.34 | ||||
Avg LOS with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 4.33 | ||||
Readmission Rate at DRG | 17.57 | ||||
Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 13.53 | ||||
Unplanned Readmission Rate at DRG | 12.56 | ||||
Unplanned Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 9.53 | ||||
Total Medicare payments at DRG | $3,254,711,780 | ||||
Total Medicare payments with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $3,011,994 | ||||
Total Medicare payment per Day at DRG | $1,504 | ||||
Total Medicare payment per Day with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $1,464 | ||||
Total Medicare payment per Hospitalization at DRG | $6,521 | ||||
Total Medicare payment per Hospitalization with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $6,341 | ||||
Total Medicare Charges at DRG | $16,863,396,143 | ||||
Total Medicare Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $15,011,909 | ||||
Avg Charges at DRG | $33,785 | ||||
Avg Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $31,604 | ||||
Mortality Rate at DRG | 1.33 | ||||
Mortality Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 19.89 | ||||
SNF Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 17.05 | ||||
Home Discharge Rate at DRG | 49.27 | ||||
Home Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 55.16 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 607: MINOR SKIN DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 270,209 | ||||
Total Hospitalizations with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 301 | ||||
DRG Share of Total Hospitalizations | 0.82 | ||||
% of Total ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter in DRG | 1.99 | ||||
Avg LOS at DRG | 4.84 | ||||
Avg LOS with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 4.58 | ||||
Readmission Rate at DRG | 22.35 | ||||
Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 19.3 | ||||
Unplanned Readmission Rate at DRG | 16.33 | ||||
Unplanned Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 13.68 | ||||
Total Medicare payments at DRG | $1,824,333,389 | ||||
Total Medicare payments with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $1,990,340 | ||||
Total Medicare payment per Day at DRG | $1,395 | ||||
Total Medicare payment per Day with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $1,443 | ||||
Total Medicare payment per Hospitalization at DRG | $6,752 | ||||
Total Medicare payment per Hospitalization with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $6,612 | ||||
Total Medicare Charges at DRG | $9,128,673,695 | ||||
Total Medicare Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $9,740,907 | ||||
Avg Charges at DRG | $33,784 | ||||
Avg Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $32,362 | ||||
Mortality Rate at DRG | 1.32 | ||||
Mortality Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 39.0 | ||||
SNF Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 32.56 | ||||
Home Discharge Rate at DRG | 24.73 | ||||
Home Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 27.57 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 231,410 | ||||
Total Hospitalizations with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 220 | ||||
DRG Share of Total Hospitalizations | 0.7 | ||||
% of Total ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter in DRG | 1.46 | ||||
Avg LOS at DRG | 7.29 | ||||
Avg LOS with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 7.66 | ||||
Readmission Rate at DRG | 25.54 | ||||
Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 21.8 | ||||
Unplanned Readmission Rate at DRG | 18.36 | ||||
Unplanned Readmission Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 15.64 | ||||
Total Medicare payments at DRG | $2,801,759,007 | ||||
Total Medicare payments with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $2,546,247 | ||||
Total Medicare payment per Day at DRG | $1,661 | ||||
Total Medicare payment per Day with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $1,510 | ||||
Total Medicare payment per Hospitalization at DRG | $12,107 | ||||
Total Medicare payment per Hospitalization with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $11,574 | ||||
Total Medicare Charges at DRG | $13,366,030,360 | ||||
Total Medicare Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $12,888,156 | ||||
Avg Charges at DRG | $57,759 | ||||
Avg Charges with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | $58,583 | ||||
Mortality Rate at DRG | 7.21 | ||||
Mortality Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | NA | ||||
SNF Discharge Rate at DRG | 32.47 | ||||
SNF Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 29.09 | ||||
Home Discharge Rate at DRG | 20.84 | ||||
Home Discharge Rate with ICD T378X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter | 24.55 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
SOUTH SHORE HOSPITAL | 55 FOGG ROAD | SOUTH WEYMOUTH | MA | 02190 | 40 |
ANNE ARUNDEL MEDICAL CENTER | 2001 MEDICAL PARKWAY | ANNAPOLIS | MD | 21401 | 40 |
BAPTIST ST. ANTHONY'S HOSPITAL | 1600 WALLACE BLVD | AMARILLO | TX | 79106 | 38 |